Covid19 Fears Cause Apprehension Among Youth to Get HIV Treatment
- The eThekwini Municipality stated that it was the first city in the province to implement the HIV/AIDS, Tuberculosis, and Sexually Transmitted Infections Behavioral Campaign Program
- The Municipality launched a one-of-a-kind initiative to reduce the frequency of new infections among the city's youth
- Due to the pandemic, the amount of patients who are scared to attend local clinics and hospitals to obtain their medication necessitates the program
PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly News on your News Feed!
DURBAN - In a declaration, eThekwini confirmed that it was the first municipality in KwaZulu-Natal to introduce a HIV/AIDS, Tuberculosis, and Sexually Transmitted Infections (STI) Behavioral Campaign Programme, which intends to combat the diseases among millennials.
On Tuesday, 5 October, the eThekwini Municipality initiated a unique campaign to decrease the prevalence of new infections among the city's youngsters.
Following an increase in the number of patients who had stopped taking their medication due to the pandemic and were afraid to visit local clinics and hospitals to acquire their medication, the new initiative was seen as a necessary and a critical next step.
Source: Getty Images
The initiative also follows as a response to an increase in HIV infections, which are most common among adolescent girls and young women between the ages of 15 and 24.
Enjoy reading our stories? Download the BRIEFLY NEWS app on Google Play now and stay up-to-date with major South African news!
Following reports by The South African, at the debut of the programme at the Cato Crest Community Hall, eThekwini Mayor Mxolisi Kaunda appealed with Millenials to utilise the facilities to defend themselves and implored those diagnosed with HIV/AIDS to receive treatment.
According to SABC News, in light of the newly implemented initiative and campaign kickoff, Mayor Mxolisi Kaunda paid a visit to the Cato Manor Clinic and Children's Home.
Covid19: Pfizer jab protects against severe symptoms for at least 6 months
Previously, Briefly News reported that after receiving the second Pfizer BioNTech Covid19 vaccine, efficacy lasts for at least six months. The effectiveness fell from 88% to 47% just six months after the second dose.
The news follows information that was publicised on Monday, 4 October. It follows United States health authorities taking into consideration the possibility of booster shots. Prior information gathered from trials has revealed that vaccinations safeguard patients from hospitalisation.
The Lancet's study calculates the efficacy of the jab in a real-world situation. Pfizer alongside Kaiser Permanente studied information from 3.4 million people residing in southern California. Approximately one-third of the residents were full vaxxed by August this year.
Source: Briefly News
